Compare APPN & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APPN | AORT |
|---|---|---|
| Founded | 1999 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2017 | 1996 |
| Metric | APPN | AORT |
|---|---|---|
| Price | $21.71 | $38.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $33.83 | ★ $49.40 |
| AVG Volume (30 Days) | ★ 633.5K | 415.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 101.59 | ★ 165.62 |
| EPS | 0.02 | ★ 0.21 |
| Revenue | $226,743,000.00 | ★ $298,836,000.00 |
| Revenue This Year | $13.79 | $14.20 |
| Revenue Next Year | $10.56 | $11.20 |
| P/E Ratio | $1,077.50 | ★ $179.90 |
| Revenue Growth | ★ 28.29 | 18.01 |
| 52 Week Low | $19.89 | $22.68 |
| 52 Week High | $46.06 | $48.25 |
| Indicator | APPN | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 39.78 | 58.61 |
| Support Level | $19.89 | $34.15 |
| Resistance Level | $27.22 | $44.29 |
| Average True Range (ATR) | 1.14 | 1.37 |
| MACD | -0.07 | 0.39 |
| Stochastic Oscillator | 34.15 | 92.17 |
Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its Domestic operations, and also has its presence Internationally.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.